219 related articles for article (PubMed ID: 10822325)
1. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.
Hara T; Yamashita S; Aiba H; Nihei K; Koide N; Good RA; Takeshita K
J Neurovirol; 2000 Apr; 6(2):121-6. PubMed ID: 10822325
[TBL] [Abstract][Full Text] [Related]
2. Role of the Th1 and Th17 Pathway in Subacute Sclerosing Panencephalitis.
Uygun DFK; Uygun V; Burgucu D; Ekinci NÇ; Sallakçı N; Filiz S; Köksoy S; Haspolat Ş; Yeğin O
J Child Neurol; 2019 Nov; 34(13):815-819. PubMed ID: 31309861
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis.
Finke D; Brinckmann UG; ter Meulen V; Liebert UG
J Virol; 1995 Sep; 69(9):5469-74. PubMed ID: 7636992
[TBL] [Abstract][Full Text] [Related]
4. Detection of interleukin 10 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
Mistchenko AS; Fornari MC; Viegas M; Barrero PR; Diez RA
J Neurovirol; 2005 Feb; 11(1):66-9. PubMed ID: 15804961
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity to measles virus in subacute sclerosing panencephalitis.
Yamanaka T; Chiba S; Nakao T; Okabe N; Takahashi N
Tohoku J Exp Med; 1977 Jun; 122(2):175-81. PubMed ID: 302045
[TBL] [Abstract][Full Text] [Related]
6. Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles.
Hankins RW; Black FL
J Clin Microbiol; 1986 Sep; 24(3):324-9. PubMed ID: 3531224
[TBL] [Abstract][Full Text] [Related]
7. Measles-vaccinated Israeli boy with subacute sclerosing panencephalitis.
Har-Even R; Aichenbaum S; Rabey JM; Livne A; Bistritzer T
Pediatr Neurol; 2011 Jun; 44(6):467-70. PubMed ID: 21555060
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 (-1188) A/C and interferon-γ (+874) A/T gene polymorphisms in subacute sclerosing panencephalitis patients.
Dundar NO; Gencpinar P; Sallakci N; Duman O; Haspolat S; Anlar B; Yegin O
J Neurovirol; 2016 Oct; 22(5):661-665. PubMed ID: 27103395
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.
Pauksen K; Sjölin J; Linde A; Alm G; Andersson B; Lönnerholm G; Ljungman P
Bone Marrow Transplant; 1997 Aug; 20(4):317-23. PubMed ID: 9285547
[TBL] [Abstract][Full Text] [Related]
10. Measles virus and mumps virus induce gamma interferon differently in human lymphocyte cultures.
Nakayama T; Urano T; Osano M; Maehara N; Sasaki K; Makino S
J Infect Dis; 1987 May; 155(5):1051-4. PubMed ID: 2951448
[No Abstract] [Full Text] [Related]
11. SSPE (subacute sclerosing panencephalitis): Is measles vaccination promotive or preventive?
McDonald R
Clin Pediatr (Phila); 1977 Feb; 16(2):124-7. PubMed ID: 832436
[No Abstract] [Full Text] [Related]
12. Detection of measles virus antigen(s) in peripheral lymphocytes from patients with subacute sclerosing panencephalitis.
Wrzos H; Kulczycki J; Laskowski Z; Matacz D; Brzosko WJ
Arch Virol; 1979; 60(3-4):291-7. PubMed ID: 389202
[TBL] [Abstract][Full Text] [Related]
13. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.
Dhiman N; Ovsyannikova IG; Ryan JE; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Clin Exp Immunol; 2005 Dec; 142(3):498-504. PubMed ID: 16297162
[TBL] [Abstract][Full Text] [Related]
14. Subacute sclerosing panencephalitis: a preventable disease that needs to be prevented.
Bale JF
Neurology; 2004 Oct; 63(8):1352-3. PubMed ID: 15505147
[No Abstract] [Full Text] [Related]
15. Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus.
Yentür SP; Demirbilek V; Gurses C; Baris S; Kuru U; Ayta S; Yapici Z; Adin-Cinar S; Uysal S; Celik Yilmaz G; Onal E; Cokar O; Saruhan-Direskeneli G
PLoS One; 2021; 16(1):e0245077. PubMed ID: 33411786
[TBL] [Abstract][Full Text] [Related]
16. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
Pallivathucal LB; Noymer A
Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea.
Mgone CS; Mgone JM; Takasu T; Miki K; Kawanishi R; Asuo PG; Kono J; Komase K; Alpers MP
Trop Med Int Health; 2003 Mar; 8(3):219-27. PubMed ID: 12631311
[TBL] [Abstract][Full Text] [Related]
18. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis.
Hofman FM; Hinton DR; Baemayr J; Weil M; Merrill JE
Clin Immunol Immunopathol; 1991 Mar; 58(3):331-42. PubMed ID: 1900461
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols.
Haspolat S; Anlar B; Köse G; Coskun M; Yegin O
J Child Neurol; 2001 Jun; 16(6):417-20. PubMed ID: 11417607
[TBL] [Abstract][Full Text] [Related]
20. Measles immunoglobulins in subacute sclerosing panencephalitis.
Connolly JH; Haire M; Hadden DS
Br Med J; 1971 Jan; 1(5739):23-5. PubMed ID: 4099413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
